ישראל -
עברית -
Ministry of Health
פרוטופיק % 0.03
dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.03 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).
ישראל -
עברית -
Ministry of Health
פרוטופיק % 0.1
dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.1 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).
ישראל -
עברית -
Ministry of Health
פרוגרף 1 מג
astellas pharma international b.v., israel - tacrolimus - קפסולות - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
ישראל -
עברית -
Ministry of Health
פרוגרף 1 מג
astellas pharma international b.v., israel - tacrolimus - קפסולות - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
ישראל -
עברית -
Ministry of Health
פרוגרף 5 מג
astellas pharma international b.v., israel - tacrolimus - קפסולות - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
ישראל -
עברית -
Ministry of Health
פרוגרף 5 מג
astellas pharma international b.v., israel - tacrolimus - קפסולות - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
ישראל -
עברית -
Ministry of Health
פרוגרף 0.5 מג
astellas pharma international b.v., israel - tacrolimus - קפסולות - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
ישראל -
עברית -
Ministry of Health
פרוגרף 0.5 מג
astellas pharma international b.v., israel - tacrolimus - קפסולות - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.
ישראל -
עברית -
Ministry of Health
טקרוסל 0.5 מג
padagis israel agencies ltd, israel - tacrolimus as monohydrate - קפסולות - tacrolimus as monohydrate 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.
ישראל -
עברית -
Ministry of Health
טקרוסל 1 מג
padagis israel agencies ltd, israel - tacrolimus as monohydrate - קפסולות - tacrolimus as monohydrate 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.